Literature DB >> 717543

Desensitization of the neutrophil aggregation response to chemotactic factors.

J T O'Flaherty, D L Kreutzer, H S Showell, E L Becker, P A Ward.   

Abstract

In the presence of Ca2+ and Mg2+, the chemotactic fragment of C5, the synthetic chemotactic oligopeptide formyl-methionyl-leucyl-phenyl-alanine, and the ionophore A23187 aggregated human neutrophils. Aggregation induced by the two chemotactic factors was transient and reversed within 2 to 4 minutes after exposure; aggregation induced by A23187 was sustained and continued to increase over 15 minutes. In the absence of the bivalent cations, none of these three agents aggregated the cells. If bivalent cations were added after cell contact with a chemotactic factor, aggregation was detected after, but not before, addition of the cations. Under these conditions, the magnitude of the aggregation response was sharply reduced: cells preincubated with a chemotactic factor for longer than 2 to 4 minutes aggregated minimally after addition of bivalent cations. Moreover, cells preincubated with a chemotactic factor for 4 minutes, exposed to bivalent cations, and then rechallenged with the same chemotactic factor also showed a minimal aggregation response, ie, the cells were "desensitized" to the original stimulus. However, cells desensitized to one of the chemotactic factors still aggregated prominently when exposed to the other chemotactic factor or to A23187. Cells could not be desensitized to the ionophore A23187. Desensitization of the neutrophil aggregation response closely resembles desensitization of mast cell and leukocyte degranulation. Degranulation and aggregation appear to be closely related cellular responses to immunologic stimuli. Both responses may reflect alterations in surface membrane permeability to bivalent cations and/or changes in surface membrane adhesiveness to other biologic membranes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 717543      PMCID: PMC2018345     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Relationships between calcium and cyclic nucleotides in cell activation.

Authors:  H Rasmussen; D B Goodman
Journal:  Physiol Rev       Date:  1977-07       Impact factor: 37.312

2.  The effects of extracellular K+, Na+ and Ca++ on lysosomal enzyme secretion from polymorphonuclear leukocytes.

Authors:  H J Showell; P H Naccache; R I Sha'afi; E L Becker
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes.

Authors:  J T O'Flaherty; D L Kreutzer; P A Ward
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

4.  Substances which aggregate neutrophils. Mechanism of action.

Authors:  J T O'Flaherty; H J Showell; E L Becker; P A Ward
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

5.  Influence of extracellular Ca2+ and Mg2+ on chemotactic factor-induced neutrophil aggregation.

Authors:  J T O'Flaherty; H J Showell; P A Ward
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

6.  Mechanism of histamine release by formyl methionine-containing peptides.

Authors:  R P Siraganian; W A Hook
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

7.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

8.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Changes in ionic movements across rabbit polymorphonuclear leukocyte membranes during lysosomal enzyme release. Possible ionic basis for lysosomal enzyme release.

Authors:  P H Naccache; H J Showell; E L Becker; R I Sha'afi
Journal:  J Cell Biol       Date:  1977-12       Impact factor: 10.539

10.  STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.

Authors:  L M LICHTENSTEIN; A G OSLER
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

View more
  7 in total

1.  Calcium ionophore A23187 induces release of chemokinetic and aggregating factors from polymorphonuclear leucocytes.

Authors:  M A Bray; A W Ford-Hutchinson; M E Shipley; M J Smith
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

2.  The dependence on Ca2+ of phosphatidylinositol breakdown and enzyme secretion in rabbit neutrophils stimulated by formylmethionyl-leucylphenylalanine or ionomycin.

Authors:  S Cockcroft; J P Bennett; B D Gomperts
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

3.  Leukotriene B4: biological activities and the cytoskeleton.

Authors:  F M Cunningham; M J Smith
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

4.  Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.

Authors:  E A Ham; D D Soderman; M E Zanetti; H W Dougherty; E McCauley; F A Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

5.  Involvement of bivalent cations and arachidonic acid in neutrophil aggregation.

Authors:  J T O'Flaherty
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

6.  Protein kinase activity is associated with CD63 in melanoma cells.

Authors:  Joji Iida; Amy P N Skubitz; James B McCarthy; Keith M Skubitz
Journal:  J Transl Med       Date:  2005-11-30       Impact factor: 5.531

7.  A Critical Reappraisal of Neutrophil Extracellular Traps and NETosis Mimics Based on Differential Requirements for Protein Citrullination.

Authors:  Maximilian F Konig; Felipe Andrade
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.